Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis: More than regulation of blood pressure?

Hypertension

Volumn 50, Issue 4, 2007, Pages 596-599

  Chappell, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE;

BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME REGULATION; GLOMERULUS BASEMENT MEMBRANE; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KNOCKOUT MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; WILD TYPE;

BLOOD PRESSURE; BRAIN; HEART; HUMANS; KIDNEY; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM;

EID: 34548851716     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.076216     Document Type: Review

References (33)

1. 2 receptor comes of age. Hypertension. 2005;45:840-844.
2. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Comm. 2006;350:1026-1031.
3. Shaltout HA, Westwood B, Averill DB, Ferrario CM, Figueroa J, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol. 2007;292:F82-F91.
4. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. In: Suzuki H, Saruta T, eds. Kidney and Blood Pressure Regulation. Basel, Switzerland: Karger; 2004:77-89.
5. Elased KM, Cunha TS, Gurley SB, Coffman TM, Morris M. New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension. 2006;47:1010 -1017.
6. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Beitbart RE, Acton SL, Rockman HA, Coffman TM. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest. 2006;116:2218-2225.
7. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM, Scholey JW. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol. 2006;168:1808-1820.
8. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003;41:392-397.
9. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Battle D. ACE and ACE2 activity in diabetic mice. Diabetes. 2006;55:2132-2139.
10. Benter IF, Yousif MHM, Cojocel C, Al-Maghrebi M, Diz DI. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol. 2007;292:H666-H672.
11. Singh R, Singh A, Leehey DJ. A novel mechanism for angiotensin II formation in streptozoticin-diabetic rat glomeruli. Am J Physiol Renal Physiol. 2005;288:F1183-F1190.
12. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 2006;69:2212-2218.
13. Diez-Freire C, Vasquez J, Correa de Adjounian MF, Ferrari MFR, Yuan L, Silver X, Torres R, Raizada MK. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics. 2006;27:12-19.
14. Pan C-H, Lin J-L, Lai L-P, Chen C-L, Huang SKS, Lin C-S. Downregulation of angiotensin converting enzyme II is associated with pacinginduced sustained atrial fibrillation. FEBS Lett. 2007;581:526-534.
15. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the Mas receptor. Am J Physiol Heart Circ Physiol. 2005;289:H1560-H1566.
16. Menon J, Sota-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of a human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007;67:2809-2815.
17. McCollum LT, Gallagher PE, Ferrario CM, Tallant EA Angiotensin-(1-7) reduces COX-2 in cardiac fibroblasts [abstract]. Hypertension. 2006;48:79.
18. Grobe JL, Mecca AP, Mao H, Katovitch MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H2417-H2423.
19. Oudit GY, Kassiri Z, Patel MP, Chappell MC, Buany J, Backx PH, Tsushima RG, Scholey JW, Khokha R, Penninger JM. Angiotensin II oxidative stress and inflammation mediate the age dependent cardiomyopathy in ACE2 null mice. Cardiovascular Res. 2007;75:29-39.
20. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JXJ, Greenberg BH. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol. 2005;289:H2356-H2363.
21. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovitch MJ. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol. 2007;292:H736-H742.
22. Santos RAS, Castro CH, Gava E, Pinheiro SVB, Almeida AP, de Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT, Ferreira AJ. Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor Mas knockout mice. Hypertension. 2006;47:996-1002.
23. Benter IF, Yousif MHM, Anim JT, Cojocel C, Diz DI. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol. 2006;290:H684-H691.
24. Sampaio WO, dos Santos RA, Faria-Silva R, de Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185-192.
25. Wilsdorf T, Gainer JV, Murphey LJ, Vaughan DE, Brown NJ. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension. 2001;37:1136-1140.
26. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;292:R373-R381.
27. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension. 2007;49:926-931.
28. Sakima A, Averill DB, Gallagher PE, Oden SD, Tommasi EN, Ferrario CM, Diz DI. Impaired heart rate baroreflex in older rats: role for endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension. 2005;46:333-340.
29. Diz DI, Tommasi EN, Ferrario CM, Tallant EA, Gallagher PE ACE2 inhibition in the nucleus of the solitary tract reduces baroreceptor reflex sensitivity [abstract]. Hypertension. 2006;48:220.
30. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for angiotensin II and angiotensin-(1-7) in the regulation of angiotensin converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2005;290:C240-C246.
31. Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R, Abassi Z. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Research. 2005;97:946-953.
32. Tallant EA, Ferrario CM, Gallagher PE. Differential regulation of cardiac angiotensin converting enzyme 2 (ACE2) and ACE by aldosterone [abstract]. Hypertension. 2005;46:886.
33. Schiffrin E. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.